Skip to main content
. 2022 Apr 2;28:e934447-1–e934447-15. doi: 10.12659/MSM.934447

Table 1.

Clinicopathological characteristics of the selected patients.

Non-surgery
N=841
Surgery
N=496
P value
Sex <0.001
 Female 561 (66.7%) 378 (76.2%)
 Male 280 (33.3%) 118 (23.8%)
Race 0.015
 Black 136 (16.2%) 61 (12.3%)
 White 598 (71.1%) 390 (78.6%)
 Other 107 (12.74%) 45 (9.07%)
Age 0.303
 ≤65 371 (44.1%) 234 (47.2%)
 >65 470 (55.9%) 262 (52.8%)
Marital status 0.112
 Married 441 (52.4%) 289 (58.3%)
 Unmarried 360 (42.8%) 188 (37.9%)
 Unknown 40 (4.76%) 19 (3.83%)
Grade <0.001
 I 7 (0.83%) 38 (7.66%)
 II 58 (6.90%) 180 (36.3%)
 III 128 (15.2%) 213 (42.9%)
 IV 7 (0.83%) 21 (4.23%)
 Unknown 641 (76.2%) 44 (8.87%)
T <0.001
 T1 113 (13.4%) 25 (5.04%)
 T2 6 (0.71%) 151 (30.4%)
 T3 345 (41.0%) 285 (57.5%)
 T4 69 (8.20%) 21 (4.23%)
 Unknown 308 (36.6%) 14 (2.82%)
N <0.001
 N0 348 (41.4%) 266 (53.6%)
 N1 219 (26.0%) 151 (30.4%)
 N2 126 (15.0%) 44 (8.87%)
 Unknown 148 (17.6%) 35 (7.06%)
Radiation 0.016
 None/Unknown 784 (93.2%) 443 (89.3%)
 Yes 57 (6.78%) 53 (10.7%)
Chemotherapy 0.036
 No/Unknown 326 (38.8%) 222 (44.8%)
 Yes 515 (61.2%) 274 (55.2%)
Regional lymph nodes <0.001
 Negative 6 (0.71%) 48 (9.68%)
 Positive 40 (4.76%) 133 (26.8%)
 Unknown 795 (94.5%) 315 (63.5%)
Bone 0.21
 No 779 (92.6%) 469 (94.6%)
 Yes 62 (7.37%) 27 (5.44%)
Brain 0.684
 No 829 (98.6%) 491 (99.0%)
 Yes 12 (1.43%) 5 (1.01%)
Liver 0.001
 No 248 (29.5%) 193 (38.9%)
 Yes 593 (70.5%) 303 (61.1%)
Lung <0.001
 No 707 (84.1%) 466 (94.0%)
 Yes 134 (15.9%) 30 (6.05%)
DLN 0.001
 No 684 (81.3%) 438 (88.3%)
 Yes 157 (18.7%) 58 (11.7%)
Tumor size <0.001
 ≤1 23 (2.73%) 14 (2.82%)
 ≤3 64 (7.61%) 121 (24.4%)
 ≤5 91 (10.8%) 92 (18.5%)
 >5 153 (18.2%) 87 (17.5%)
 Unknown 510 (60.6%) 182 (36.7%)
Histology <0.001
 Adenocarcinomas 655 (77.9%) 416 (83.9%)
 Epithelial 103 (12.2%) 32 (6.45%)
 Mucinous 29 (3.45%) 34 (6.85%)
 Others 54 (6.42%) 14 (2.82%)